Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Deep Venous Thrombosis: full-pipeline trial registry
3 of 10 indexed Deep Venous Thrombosis trials are currently recruiting.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Deep Venous Thrombosis: 10 US clinical trials tracked, 3 recruiting.
Deep Venous Thrombosis is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Anthos Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition deep-venous-thrombosis
OPEN 3 | RECR 30% | LATE 4 | EARLY 3 | RANK #1724 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)
Deep Venous Thrombosis lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Deep Venous Thrombosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Deep Venous Thrombosis is recruiting below its size-band peers.
3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Deep Venous Thrombosis trials is spread across many organizations.
Anthos Therapeutics accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Deep Venous Thrombosis enrolment sits around 300 participants.
Median target enrolment is 300 among the 10 trials that report a genuine target (sentinel values excluded). 1 of those (10%) plan for fewer than 100 participants.
-
Deep Venous Thrombosis research is mostly interventional.
9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Inari Medical
NCT05701917
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Memorial Sloan Kettering Cancer Center
NCT07399977
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Yale University
NCT04924322
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
Anthos Therapeutics
NCT05171075
FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease
University of Texas Southwestern Medical Center
NCT04583878
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NCT01828697
The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome
Sir Mortimer B. Davis - Jewish General Hospital
NCT00143598
Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
Sanofi
NCT00311090
Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
University of Utah
NCT02687204
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
Sanford Health
NCT02889562
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Deep Venous Thrombosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Deep Venous Thrombosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Deep Venous Thrombosis page
10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Deep Venous Thrombosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Anthos Therapeutics sponsors the most Deep Venous Thrombosis trials on record, review their full trial history before evaluating a specific study. See Anthos Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Deep Venous Thrombosis condition card totals 10 registered trials; most-linked intervention Placebo (for Avidin); top US site state Oklahoma. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.